SCRC Partner Profile: A Textbook Transformation at Biogen-Idec
Supply Chain View from the Field
AUGUST 8, 2013
The company discovers, develops, manufactures, and markets biological products for treating conditions such as multiple sclerosis and non-Hodgkin’s lymphoma. It was formed from the November 2003 merger of Biogen, Inc. and IDEC Pharmaceuticals Corp. Several factors had converged to spark the maturity assessment.
Let's personalize your content